Journal
Cancers
Publication Date
9-30-2025
Volume
17
Issue
19
First Page
3177
Document Type
Open Access Publication
DOI
10.3390/cancers17193177
Rights and Permissions
Chen M, Kane T, Chen I, Supabphol S, Zhang X, Wolfarth AA, Choi D, Li L, Goedegebuure SP, Gillanders WE. Long-Acting Recombinant IL-7 (rhIL-7-hyFc) Enhances the Primary and Memory Neoantigen-Specific Immune Response to Breast Cancer Personalized Cancer Vaccines. Cancers (Basel). 2025 Sep 30;17(19):3177. doi: 10.3390/cancers17193177 Copyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/ licenses/by/4.0/).
Recommended Citation
Chen, Michael; Kane, Thomas; Chen, Ina; Supabphol, Suangson; Zhang, Xiuli; Wolfarth, Alexandra A; Choi, Donghoon; Li, Lijin; Goedegebuure, S Peter; and Gillanders, William E, "Long-acting recombinant IL-7 (rhIL-7-hyFc) enhances the primary and memory neoantigen-specific immune response to breast cancer personalized cancer vaccines." Cancers. 17, 19. 3177 (2025).
https://digitalcommons.wustl.edu/oa_4/5557
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
